Genotype-, aging-dependent abnormal caspase activity in Huntington disease blood cells
Ferdinando Squitieri1, Vittorio Maglione, Sara Orobello
1Neurogenetics Unit and Rare Diseases Centre, IRCCS Neuromed, Pozzilli (IS), Italy. francesco.fornai@med.unipi.it
Insights
Huntington's Disease (HD) involves CAG repeat expansion in huntingtin (htt). This study reveals genotype-dependent caspase activity, reduced cell viability, and mitochondrial issues in HD patient blood cells, highlighting peripheral tissue relevance.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- Huntington's Disease (HD) arises from CAG trinucleotide repeat expansions (>36) in the huntingtin (htt) gene.
- The expanded polyglutamine (polyQ) tract in htt causes neuronal and peripheral tissue dysfunction.
- Previous studies documented htt functions, but comprehensive caspase activity analysis in HD peripheral cells was limited.
Purpose of the Study:
- To investigate genotype- and time-dependent caspase activity (caspase 2, 3, 6, 8, 9) in cultured blood cells from HD patients.
- To assess cell viability and mitochondrial morphology alterations in relation to HD genotype.
- To explore the role of peripheral tissues, like blood cells, as potential tools for HD research and biomarker discovery.
Main Methods:
- Cultured blood cells from HD patients with varying CAG repeat sizes (homozygous, high-size heterozygous, low-size heterozygous) and controls were analyzed.
- Caspa se activities (caspase 2, 3, 6, 8, 9) were measured.
- Cell viability assays and mitochondrial morphology assessments were performed.
- Cells were treated with cyanide to evaluate caspase responses.
Main Results:
- Patients with homozygous or high-size heterozygous mutations (including Juvenile HD) showed significantly increased activities of caspases 2, 3, 6, 8, and 9.
- These patients also exhibited decreased cell viability and pronounced mitochondrial morphological abnormalities compared to controls and low-mutation carriers.
- Cyanide treatment exacerbated caspase activity, particularly in homozygous and high-expansion heterozygous cells, underscoring the role of caspase 8 and 9 as initiators in HD.
- Age-dependent abnormalities in peripheral cells correlated with mutation toxicity, suggesting htt dosage or wild-type htt levels influence HD progression.
Conclusions:
- Genotype and time significantly impact caspase activity, cell viability, and mitochondrial morphology in HD patient blood cells.
- Peripheral blood cells offer a valuable model for studying HD pathogenesis and identifying potential biomarkers.
- The findings suggest that mutated htt dosage or the absence of wild-type htt may be critical factors in HD clinical development and progression.
Abstract:
Huntington's Disease (HD) is caused by trinucleotide CAG repeat expansion >36 in huntingtin (htt), a protein with several documented functions. The elongated polyglutamine (polyQ) stretch in the N-terminal region of htt leads to dysfunctional and degenerative events in neurons and peripheral tissues. In this study, by extending the analysis to several caspase activities (i.e. caspase 2, 3, 6, 8 and 9), we describe genotype- and time- dependent caspase activity abnormalities, decreased cell viability and a large set of alterations in mitochondria morphology, in cultured blood cells from HD patients. Patients homozygous for CAG repeat mutations and heterozygous with high size mutations causing juvenile onset (JHD) presented significantly increased caspase 2, 3, 6, 8 and 9 activities, decreased cell viability and pronounced morphological abnormalities, compared with cells carrying low mutation size and controls. After cyanide treatment, all caspases increased their activities in homozygous and highly expanded heterozygous cells, caspase 8 and 9 increased also in those cells carrying low-size mutations, remarking their key role as 'caspase initiators' in HD. The remarkable ageing-dependent abnormalities in peripheral cells carrying particularly toxic mutations (i.e. homozygotes' and JHD's blood cells) points out the potential dependence of clinical HD development and progression on either mutated htt dosage or missing wild type htt. Peripheral tissues (i.e. blood cells) may theoretically represent an important tool for studying HD mechanisms and searching for new biomarkers, according to the patients' genotype.
Related Concept Videos
Caspases
Huntington Disease l: Introduction
The Intrinsic Apoptotic Pathway


